Literature DB >> 22965903

Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.

Pratima Sharma1, Douglas E Schaubel, Emily E Messersmith, Mary K Guidinger, Robert M Merion.   

Abstract

Under an ideal implementation of Model for End-Stage Liver Disease (MELD)-based liver allocation, the only factors that would predict deceased donor liver transplantation (DDLT) rates would be the MELD score, blood type, and donation service area (DSA). We aimed to determine whether additional factors are associated with DDLT rates in actual practice. Data from the Scientific Registry of Transplant Recipients for all adult candidates wait-listed between March 1, 2002 and December 31, 2008 (n = 57,503) were analyzed. Status 1 candidates were excluded. Cox regression was used to model covariate-adjusted DDLT rates, which were stratified by the DSA, blood type, liver-intestine policy, and allocation MELD score. Inactive time on the wait list was not modeled, so the computed DDLT hazard ratios (HRs) were interpreted as active wait-list candidates. Many factors, including the candidate's age, sex, diagnosis, hospitalization status, and height, prior DDLT, and combined listing for liver-kidney or liver-intestine transplantation, were significantly associated with DDLT rates. Factors associated with significantly lower covariate-adjusted DDLT rates were a higher serum creatinine level (HR = 0.92, P < 0.001), a higher bilirubin level (HR = 0.99, P = 0.001), and the receipt of dialysis (HR = 0.83, P < 0.001). Mild ascites (HR = 1.15, P < 0.001) and hepatic encephalopathy (grade 1 or 2, HR = 1.05, P = 0.02; grade 3 or 4, HR = 1.10, P = 0.01) were associated with significantly higher adjusted DDLT rates. In conclusion, adjusted DDLT rates for actively listed candidates are affected by many factors aside from those integral to the allocation system; these factors include the components of the MELD score itself as well as candidate factors that were considered but were deliberately omitted from the MELD score in order to keep it objective. These results raise the question whether additional candidate characteristics should be explicitly incorporated into the prioritization of wait-list candidates because such factors are already systematically affecting DDLT rates under the current allocation system.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22965903      PMCID: PMC3518743          DOI: 10.1002/lt.23548

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  17 in total

1.  Disparity in use of orthotopic liver transplantation among blacks and whites.

Authors:  Andrea E Reid; Maria Resnick; YuChiao Chang; Nathan Buerstatte; Joel S Weissman
Journal:  Liver Transpl       Date:  2004-07       Impact factor: 5.799

2.  Analytical methods and database design: implications for transplant researchers, 2005.

Authors:  G N Levine; K P McCullough; A M Rodgers; D M Dickinson; V B Ashby; D E Schaubel
Journal:  Am J Transplant       Date:  2006       Impact factor: 8.086

3.  Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.

Authors:  Amit K Mathur; Nicholas H Osborne; Raymond J Lynch; Amir A Ghaferi; Justin B Dimick; Christopher J Sonnenday
Journal:  Arch Surg       Date:  2010-12

Review 4.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

Review 5.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

6.  The survival benefit of liver transplantation.

Authors:  Robert M Merion; Douglas E Schaubel; Dawn M Dykstra; Richard B Freeman; Friedrich K Port; Robert A Wolfe
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

7.  Liver transplantation for hepatocellular carcinoma: the MELD impact.

Authors:  Pratima Sharma; Vijayan Balan; Jose L Hernandez; Ann M Harper; Erick B Edwards; Hector Rodriguez-Luna; Thomas Byrne; Hugo E Vargas; David Mulligan; Jorge Rakela; Russell H Wiesner
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

8.  Results of the first year of the new liver allocation plan.

Authors:  Richard B Freeman; Russell H Wiesner; Erick Edwards; Ann Harper; Robert Merion; Robert Wolfe
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

9.  Model for end-stage liver disease (MELD) and allocation of donor livers.

Authors:  Russell Wiesner; Erick Edwards; Richard Freeman; Ann Harper; Ray Kim; Patrick Kamath; Walter Kremers; John Lake; Todd Howard; Robert M Merion; Robert A Wolfe; Ruud Krom
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

10.  Disparities in liver transplantation before and after introduction of the MELD score.

Authors:  Cynthia A Moylan; Carla W Brady; Jeffrey L Johnson; Alastair D Smith; Janet E Tuttle-Newhall; Andrew J Muir
Journal:  JAMA       Date:  2008-11-26       Impact factor: 56.272

View more
  5 in total

1.  Impact of Race and Ethnicity on Outcomes for Children Waitlisted for Pediatric Liver Transplantation.

Authors:  Douglas B Mogul; Xun Luo; Eric K Chow; Allan B Massie; Tanjala S Purnell; Kathleen B Schwarz; Andrew M Cameron; John F P Bridges; Dorry L Segev
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-03       Impact factor: 2.839

2.  Predicting chance of liver transplantation for pediatric wait-list candidates.

Authors:  Xun Luo; Douglas B Mogul; Allan B Massie; Tanveen Ishaque; John F P Bridges; Dorry L Segev
Journal:  Pediatr Transplant       Date:  2019-07-16

3.  Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era.

Authors:  Reena J Salgia; Nathan P Goodrich; Heather Simpson; Robert M Merion; Pratima Sharma
Journal:  Dig Dis Sci       Date:  2014-02-21       Impact factor: 3.199

4.  Women who undergo liver transplant have longer length of stay post-transplant compared with men.

Authors:  Jessica B Rubin; Giuseppe Cullaro; Jin Ge; Jennifer C Lai
Journal:  Liver Int       Date:  2020-05-25       Impact factor: 5.828

Review 5.  Outcomes in liver transplantation: does sex matter?

Authors:  Monika Sarkar; Kymberly D Watt; Norah Terrault; Marina Berenguer
Journal:  J Hepatol       Date:  2014-11-27       Impact factor: 25.083

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.